IB Acquisition Corp. (IBAC): Share Repurchases

Annual figures by period end, from SEC filings.

$106.13M

Year ended 2025-09-30

Period ended	Share Repurchases	Change YoY	Source filing
2025-09-30	$106.13M	n/a	2025-12-29, From 2024-10-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Share Repurchases	Change YoY
IB Acquisition Corp. (IBAC)	2025-09-30	$106.13M	n/a
NRC Health (NRC)	2025-12-31	$20.18M	-34.8%
Medpace Holdings, Inc. (MEDP)	2025-12-31	$917.39M	+440.1%
Incyte Corp (INCY)	2025-12-31	$0	-100.0%
Charles River Laboratories International, Inc. (CRL)	2025-12-27	$360.67M	+202.6%
Icon PLC (ICLR)	2025-12-31	$750.00M	+50.0%
Iqvia Holdings Inc. (IQV)	2025-12-31	$1.24B	-7.9%

Compare IBAC, NRC, MEDP, INCY side by side · Screen every company in Services-Commercial Physical & Biological Research ↗